SCHEMBL29170991

SCHEMBL29170991

COc1cc(NC2C3CC4CC2CC(O)(C4)C3)ccc1[N+](=O)[O-]

nearest known ligand 0.44

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ CYP3A4 P08684 1/20 0.44
▸ CYP2C9 P11712 1/20 0.44
▸ CYP2C19 P33261 1/20 0.44
▸ HSD11B1 P28845 7/20 0.41
▸ JAK3 P52333 2/20 0.40
▸ ALDH1A1 P00352 4/20 0.39
▸ LMNA P02545 2/20 0.39
▸ SIRT6 Q8N6T7 1/20 0.37
▸ HTT P42858 1/20 0.37
▸ TDP1 Q9NUW8 1/20 0.37
▸ JAK1 P23458 1/20 0.36
▸ EPHX2 P34913 1/20 0.36
▸ MAPT P10636 2/20 0.35
▸ KDM4E B2RXH2 1/20 0.35
▸ GAA P10253 1/20 0.35
▸ MAPK1 P28482 1/20 0.35
▸ L3MBTL1 Q9Y468 1/20 0.35
▸ IRAK4 Q9NWZ3 1/20 0.35
▸ THRB P10828 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29851507 1.00 CYP3A4 (0.44) CYP3A4CYP2C9CYP2C19HSD11B1JAK3
SCHEMBL25047230 1.00 CYP3A4 (0.44) CYP3A4CYP2C9CYP2C19HSD11B1JAK3
SCHEMBL30757919 0.86 CYP3A4 (0.42) CYP3A4CYP2C9CYP2C19HSD11B1ALDH1A1
SCHEMBL23480109 0.86 CYP3A4 (0.42) CYP3A4CYP2C9CYP2C19HSD11B1ALDH1A1
SCHEMBL23480038 0.85 HSD11B1 (0.42) CYP3A4CYP2C9CYP2C19HSD11B1ALDH1A1
SCHEMBL25047487 0.85 HSD11B1 (0.42) CYP3A4CYP2C9CYP2C19HSD11B1ALDH1A1
SCHEMBL29170993 0.85 HSD11B1 (0.42) CYP3A4CYP2C9CYP2C19HSD11B1ALDH1A1
SCHEMBL29851378 0.85 HSD11B1 (0.42) CYP3A4CYP2C9CYP2C19HSD11B1ALDH1A1
SCHEMBL23479973 0.85 CYP3A4 (0.59) CYP3A4CYP2C9CYP2C19ALDH1A1LMNA
SCHEMBL23466886 0.84 ALDH1A1 (0.43) CYP3A4CYP2C9CYP2C19HSD11B1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114929675-B Adamantane derivatives as focal adhesion kinase inhibitors 三进制药株式会社 2024-02-13 — — CN disclosed
CN-114929675-A Novel adamantane derivatives as inhibitors of focal adhesion kinase 三进制药株式会社 2022-08-19 — — CN disclosed
Send feedback